0
Skip to Content
GripRoom
Politics
Finance
ChatGPT
How To
Fun Stuff
Everything
GripRoom
Politics
Finance
ChatGPT
How To
Fun Stuff
Everything
Politics
Finance
ChatGPT
How To
Fun Stuff
Everything
Iovance Biotherapeutics Short Squeeze Potential ($20)
Jim Rogan 2/20/24 Jim Rogan 2/20/24

Iovance Biotherapeutics Short Squeeze Potential ($20)

Read More
How does CRISPR work, step by step?
Jim Rogan 1/4/24 Jim Rogan 1/4/24

How does CRISPR work, step by step?

Read More
Viking Therapeutics (VKTX) Could Squeeze to $40
Mark Armstrong 12/13/23 Mark Armstrong 12/13/23

Viking Therapeutics (VKTX) Could Squeeze to $40

Read More
Why Viking Therapeutics (VKTX) is a Buy Going into 2024
Sam Chang 12/12/23 Sam Chang 12/12/23

Why Viking Therapeutics (VKTX) is a Buy Going into 2024

Read More
Gilead and Assembly Strike a Huge Deal Amidst Biotech Bear Market
Luca Marino 10/17/23 Luca Marino 10/17/23

Gilead and Assembly Strike a Huge Deal Amidst Biotech Bear Market

Read More
Gritstone Bio Unveils Game-Changing COVID-19 Vaccine Results
Mark Armstrong 10/11/23 Mark Armstrong 10/11/23

Gritstone Bio Unveils Game-Changing COVID-19 Vaccine Results

Read More
Gritstone Bio and the Calm Before the Storm
David Stone 10/7/23 David Stone 10/7/23

Gritstone Bio and the Calm Before the Storm

Read More
The Next Moderna? How Gritstone Bio Could Dominate the Vaccine Industry
David Stone 9/28/23 David Stone 9/28/23

The Next Moderna? How Gritstone Bio Could Dominate the Vaccine Industry

Read More
10 Reasons to Invest in Moderna: A Biotech Powerhouse
Mark Armstrong 5/15/23 Mark Armstrong 5/15/23

10 Reasons to Invest in Moderna: A Biotech Powerhouse

Read More
BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance
David Stone 5/11/23 David Stone 5/11/23

BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance

Read More
Why It Takes Time for Companies to Share FDA Meeting Outcomes with Investors
Mark Armstrong 5/2/23 Mark Armstrong 5/2/23

Why It Takes Time for Companies to Share FDA Meeting Outcomes with Investors

Read More
Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology
Isha Tanaka 5/2/23 Isha Tanaka 5/2/23

Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology

Read More
11 Reasons to Invest in Virios Therapeutics
John Wilson 4/25/23 John Wilson 4/25/23

11 Reasons to Invest in Virios Therapeutics

Read More
Is BioNTech About to Take a Major Stake in Matinas BioPharma?
David Stone 4/24/23 David Stone 4/24/23

Is BioNTech About to Take a Major Stake in Matinas BioPharma?

Read More
The Growing Need for Novel Antifungals
Sarah Martinez 4/21/23 Sarah Martinez 4/21/23

The Growing Need for Novel Antifungals

Read More
Moderna's Cancer Vaccine Shows Promising Results in Melanoma Prevention
Isha Tanaka 4/16/23 Isha Tanaka 4/16/23

Moderna's Cancer Vaccine Shows Promising Results in Melanoma Prevention

Read More
Candida auris: A Growing Health Threat to Hospitalized Patients
Mark Armstrong 4/8/23 Mark Armstrong 4/8/23

Candida auris: A Growing Health Threat to Hospitalized Patients

Read More
The Impact of ChatGPT on the Healthcare Industry
Ella Bianchi 3/21/23 Ella Bianchi 3/21/23

The Impact of ChatGPT on the Healthcare Industry

Read More
Revolutionizing mRNA Therapeutics: The Promise of a Novel Oral Drug Delivery System
David Stone 3/19/23 David Stone 3/19/23

Revolutionizing mRNA Therapeutics: The Promise of a Novel Oral Drug Delivery System

Read More
10 Reasons to Invest in Biotech in 2023
Jim Rogan 2/26/23 Jim Rogan 2/26/23

10 Reasons to Invest in Biotech in 2023

Read More
Older Posts

About GripRoom Privacy Policy

Disclaimer: Nothing on this website is medical, legal, investment, or any other type of serious advice. This website is for entertainment purposes only. Always consult a professional before making an important decision.